Latest News for: genitourinary

Edit

Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (Tyra Biosciences Inc)

Public Technologies 23 Feb 2026
) Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium ... accepted for presentation at the 2026 ASCO® Genitourinary (GU) Cancers Symposium (ASCO GU).
Edit

Blue Earth Diagnostics to Highlight New POSLUMA® (Flotufolastat F 18) Study Results in Prostate Cancer at the 2026 ASCO Genitourinary Symposium (ASCO GU)

PR Newswire 18 Feb 2026
... (PET) radiopharmaceuticals, today announced that multiple presentations featuring POSLUMA® (flotufolastat F 18) will be presented at the upcoming ASCO 2026 Genitourinary Cancers Symposium (ASCO GU).
Edit

AUBMC Holds the Second Middle East Genitourinary Oncology Conference

Al Bawaba 04 Feb 2026
... management of genitourinary malignancies.
Edit

Genitourinary Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties by ...

Nasdaq Globe Newswire 19 Nov 2025
19, 2025 (GLOBE NEWSWIRE) -- The "Genitourinary Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of 290 genitourinary deals from 2016 to 2025.
  • 1
×